Viral Hepatitis Clinical Trial
Official title:
Continuing Medical Education (CME) Intervention to Improve Knowledge About Viral Hepatitis B-C: A Randomized Controlled Trial Pilot at Primary-level Hospitals in Ho Chi Minh City
Verified date | September 2022 |
Source | Pham Ngoc Thach University of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of study is identifying the effectiveness of 'continuing medical education' (CME) to primary healthcare worker to improve knowledge about viral hepatitis B-C
Status | Enrolling by invitation |
Enrollment | 88 |
Est. completion date | April 2023 |
Est. primary completion date | February 10, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 24 Years to 65 Years |
Eligibility | Inclusion Criteria: - Currently working at Outpatient department, Primary-level hospitals - Having Practicing Certificate - Not attending any long-term education - Accepting ICF Exclusion Criteria: - Not attending the full number of lessons - Not answering the questionnaire |
Country | Name | City | State |
---|---|---|---|
Vietnam | Lê H?ng Ð?c | Tháng 07 | Ho Chi Minh City |
Lead Sponsor | Collaborator |
---|---|
Pham Ngoc Thach University of Medicine |
Vietnam,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Test Scores on Knowledge about Hepatitis B-C from Baseline to 6 months | Participants have exams pre- and post-6-months-course, which is multiple choice questions. The test score is average number of correct answers. The pre- and post-6-months exams use the same structure and questions. A change in test score is the difference between test score of the post-6-months-exam and test score of the pre-course-exam. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT01195181 -
Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.
|
Phase 4 | |
Completed |
NCT04371276 -
Seroepidemiology of Viral Hepatitis in Hong Kong
|
||
Completed |
NCT01988753 -
Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases
|
||
Not yet recruiting |
NCT04113915 -
Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy
|
||
Recruiting |
NCT03743272 -
Repeatability and Reproducibility of Multiparametric MRI
|
||
Completed |
NCT06360484 -
Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus
|
||
Recruiting |
NCT01766895 -
Long-term Follow Up of Viral Hepatitis in Uremic Patients in Taiwan
|
||
Not yet recruiting |
NCT04222803 -
VIRal Hepatitis and GAllstone Disease Study
|
||
Recruiting |
NCT04304612 -
A Cost Effective and Time Saving Blood Test to Detect Six Human Bloodborne Infectious Diseases
|
||
Completed |
NCT04062253 -
Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid
|
||
Recruiting |
NCT03933384 -
Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
|
Phase 4 | |
Completed |
NCT01082419 -
Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity
|
N/A |